Complementary relationship between repetitive sequences in the SV40 early gene pre-promoter enhancing region and big-T antigen splice junction exons.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 6097770)

Published in J Theor Biol on October 21, 1984

Authors

L Burnett, A Basten, W J Hensley

Articles by these authors

(truncated to the top 100)

A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47

A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63

Error rates in Australian chemical pathology laboratories. Med J Aust (1996) 4.56

Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55

Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34

Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04

Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02

Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40

Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09

T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06

Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03

Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77

Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48

Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40

Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med (1979) 2.19

Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15

Carboxyhemoglobin, cotinine, and thiocyanate assay compared for distinguishing smokers from non-smokers. Clin Chem (1984) 2.12

Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97

The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96

Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96

Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94

Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87

Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78

Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75

Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J (1971) 1.66

Some laboratory correlates of drinking habits. Ann Clin Biochem (1978) 1.60

Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58

Specific collaboration between T and B lymphocytes across a cell impermeable membrane in vitro. Nat New Biol (1972) 1.49

Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses. Blood (1970) 1.48

Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46

Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45

Measurement of total protein is not a useful inclusion in liver function test profiles. Clin Chem (2000) 1.43

Lipoproteins, atherogenicity, age and risk of myocardial infarction. Aust N Z J Public Health (1999) 1.40

Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37

A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students. J Med Genet (2003) 1.37

A subpopulation of T cells bearing Fc receptors. J Immunol (1975) 1.35

Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33

Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31

Humoral and cell mediated responses in vitro of spleen cells from mice with thymic aplasia (nude mice). Aust J Exp Biol Med Sci (1972) 1.26

The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepr Rev (1986) 1.24

Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res (1997) 1.23

Immune function in aged mice. II. B-cell function. Cell Immunol (1977) 1.20

HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19

Randomised controlled trial of exercise in the elderly. Gerontology (1992) 1.18

Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer (1975) 1.18

Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. Proc Natl Acad Sci U S A (1990) 1.17

Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16

B cell life span: a review. Immunol Cell Biol (1997) 1.15

Suppressor cells in humoral immunity and tolerance. Br Med Bull (1976) 1.14

Influences on the lifespan of B cell subpopulations defined by different phenotypes. Eur J Immunol (1997) 1.14

Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin. J Exp Med (1983) 1.14

Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J Exp Med (1997) 1.13

Cell interactions in the immune response in vitro. I. Metabolic activities of T cells in a collaborative antibody response. Eur J Immunol (1972) 1.13

The need for central and peripheral tolerance in the B cell repertoire. Science (1990) 1.12

B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol (1995) 1.12

Double Beta-Lipoprotein: A New Genetic Variant in Man. Science (1965) 1.12

Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci U S A (1994) 1.11

Immune function in aged mice. I. T-cell responsiveness using phytohaemagglutinin as a functional probe. Cell Immunol (1977) 1.10

Suppressor T-cell memory. Nature (1978) 1.10

Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc Natl Acad Sci U S A (1991) 1.09

Immune complexes in thrombocytopenic patients: cause or effect? Br J Haematol (1980) 1.09

Immune function in aged mice. IV. Loss of T cell and B cell function in thymus-dependent antibody responses. Eur J Immunol (1978) 1.09

A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australas J Dermatol (1996) 1.08

The effect of caffeine on human performance, alone and in combination with ethanol. Psychopharmacologia (1975) 1.08

Post-mammoplasty connective tissue disease. Arthritis Rheum (1982) 1.08

Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients. Clin Exp Immunol (1988) 1.05

A rapid gas chromatographic method for the quantitation of underivatised individual free fatty acids in plasma. Clin Chim Acta (1975) 1.04

Mechanisms of tolerance to self. Curr Opin Immunol (1996) 1.04

Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol (1987) 1.04

Individuals from different populations identify multiple and diverse T-cell determinants on mycobacterial HSP70. Scand J Immunol (1994) 1.03

Loss of immune competence with age may be due to a qualitative abnormality in lymphocyte membranes. Nature (1979) 1.03

Suppressor T cells in tolerance to non-self and self antigens. Cold Spring Harb Symp Quant Biol (1977) 1.03

T cell reactivity to the purified mycobacterial antigens p65 and p70 in leprosy patients and their household contacts. Clin Exp Immunol (1990) 1.01

Decremental motor responses to repetitive nerve stimulation in ALS. Muscle Nerve (1994) 0.99

Selective cytotoxicity of anti-kappa serum for B lymphocytes. Nat New Biol (1972) 0.98

HLA-DW2, viral immunity and family studies in multiple sclerosis. J Neurol Sci (1977) 0.97

Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. J Clin Lab Immunol (1980) 0.95

Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J Exp Med (1998) 0.95

What are killer cells and what do they do? Blood Rev (1988) 0.94

T cell-dependent suppression of antibody production. I. Characteristics of suppressor T cells following tolerance induction. Eur J Immunol (1978) 0.92

Total lipodystrophy--a report of a case with peripheral neuropathy and glomerulonephritis. Aust N Z J Med (1983) 0.92

"Sneaking through": a T-cell-dependent phenomenon. Br J Cancer (1981) 0.92

The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses. Infect Immun (1992) 0.92

Antigens and allergens from the common house dust mite Dermatophagoides pteronyssinus. Part II. Identification of the major IgE-binding antigens by crossed radioimmunoelectrophoresis. J Allergy Clin Immunol (1984) 0.91

Induction of memory and effector suppressor T cells by perinatal exposure to antigen. Eur J Immunol (1984) 0.91

A role for suppressor T cells in induction of self-tolerance. Proc Natl Acad Sci U S A (1985) 0.91

An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol. Clin Chem (1979) 0.91

Human antigen-specific IgA responses in blood and secondary lymphoid tissue: an analysis of help and suppression. J Immunol (1984) 0.91

Immune function in aged mice. V. Role of suppressor cells. J Immunol (1980) 0.90

T cell clones from a non-leprosy exposed subject recognize the Mycobacterium leprae 18-kD protein. Clin Exp Immunol (1995) 0.89

Measurement of "lamellar body phospholipid" in amniotic fluid as a method for assessing fetal lung maturity. Clin Chem (1981) 0.89

Use of phenolic glycolipid 1 for serodiagnosis of leprosy in a high prevalence village in Papua New Guinea. Trans R Soc Trop Med Hyg (1987) 0.88

Detection of membrane-associated antigens on lymphoid cells by antibody coupled to staphylococcal protein A. J Immunol (1975) 0.88

Alpha-interferon (Wellferon) as an adjunct to standard surgical therapy in the management of recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol (1988) 0.88

Plasma fibrinogen and other cardiovascular disease risk factors and cataract. Ophthalmic Epidemiol (1999) 0.88

Differential co-expression of alpha-actin genes within the human heart. J Mol Cell Cardiol (1986) 0.87

The interaction of ethanol and delta9-tetrahydrocannabinol in man: effects on perceptual, cognitive and motor functions. Med J Aust (1976) 0.87

Subclinical infection with Mycobacterium leprae--a problem for leprosy control strategies. Trans R Soc Trop Med Hyg (1993) 0.87

Immune system of the gastrointestinal tract. Int Rev Physiol (1983) 0.87

Transfer factor in treatment of multiple sclerosis. Lancet (1980) 0.86